Hartmut Beck

This inventor holds 22 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 13 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hartmut Beck. Retrieved from https://idiyas.com/inventor/hartmut-beck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 17)

% Patents Active = 36.4

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 13 (Patent Applications = 24)

Average Co-Inventor Count = 10.4

ph-index = 6

Forward Citations = 59(Granted Patents)

Location History:

Cologne, DE (2011)
Köln, DE (2010 - 2015)
Wuppertal, DE (2013 - 2024)

Company Filing History:

11 out of 721

Bayer Intellectual Property Gmbh

patents

7 out of 387

Bayer Pharma Aktiengesellschaft

patents

3 out of 12,268

Bayer Aktiengesellschaft

patents

4. 2 out of 192

Bayer Schering Pharma Ag

patents

5. 1 out of 53

Aicuris Gmbh + Co. Kg.

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

Substituted S-alaninate

Anti-Inflammatory Agents

Dihydropyrazolones

Quinoline Derivatives

HIF-Prolyl-4-Hydroxylase Inhibitors

Cardiovascular Diseases

Heteroaryl Substituted

Kinase Inhibitors

Phenyltriazole Derivatives

Furopyrimidine Derivatives

Acyclically Substituted

Substituted Benzamides

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11912692 - Substituted S-alaninate derivatives (2024-02-27),

2. 11149018 - Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof (2021-10-19),

3. 11136296 - Substituted-arylethyl-2-arylquinoline-4-carboxamides and use thereof (2021-10-05),

4. 10479765 - Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents (2019-11-19),

5. 10189788 - Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents (2019-01-29),

6. 10117864 - Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof (2018-11-06),

7. 9771352 - Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof (2017-09-26),

8. 9168249 - Substituted dihydropyrazolones for treating cardiovascular and hematological diseases (2015-10-27),

9. 8987261 - Substituted dihydropyrazolones for treating cardiovascular and hematological diseases (2015-03-24),

10. 8796253 - Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis (2014-08-05),

11. 8653111 - Substituted dihydropyrazolones for treating cardiovascular and hematological diseases (2014-02-18),

12. 8609698 - Substituted dipyridyl-dihydropyrazolones and use thereof (2013-12-17),

13. 8580778 - Substituted dihydropyrazolones and their use (2013-11-12),

14. 8524699 - Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors (2013-09-03),

15. 8470811 - Substituted heterocyclylbenzylpyrazoles and use thereof (2013-06-25),

Title: The Innovative Journey of Hartmut Beck

Introduction: Hartmut Beck, a visionary inventor hailing from Köln, Germany, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Hartmut Beck's latest patents include a cutting-edge software application for optimizing energy consumption in industrial settings and a revolutionary medical device for non-invasive monitoring of vital signs.

Career Highlights: With over two decades of experience in the tech industry, Hartmut Beck has a proven track record of developing innovative solutions that have reshaped various sectors. His expertise lies in artificial intelligence, IoT, and renewable energy technologies.

Collaborations: Throughout his career, Hartmut Beck has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have led to the successful commercialization of several groundbreaking products.

Conclusion: Hartmut Beck's relentless passion for innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the field of inventing. His contributions continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.